World Pharma AIRegister

Next eventWorld Pharma AI London 2027

London

28 Apr 2027Central London

Next-Gen Drug Discovery

The premier conference series for life-science leaders, R&D directors, and AI scientists examining how machine intelligence is compressing discovery timelines, reshaping clinical trials, and unlocking precision medicine at population scale.

Book your pass

Agenda

Request the draft agenda

The programme is being finalised. Leave your details and we’ll email you the draft agenda as soon as it’s ready.

150+
Delegates
25+
Speakers
1
Day

Organisations at our events

Programme

Topics covered

  1. From Target to Candidate

    Scaling AI-Driven Drug Discovery

    • Where AI is shortening hit-to-lead and candidate selection, and what has reached the clinic so far
    • What UK data assets — UK Biobank, Genomics England — change about target identification
    • How big pharma partners with AI-native biotechs: deal structures, IP and how success is judged
  2. Smarter Clinical Trials

    Design, Recruitment & Execution

    • Protocol optimisation, digital twins and synthetic control arms: what MHRA, EMA and FDA will accept
    • Finding patients faster through NHS data, DigiTrials and real-world evidence
    • AI-authored protocols, ICFs and study reports: where human sign-off has to stay
  3. Data Foundations & Governance

    AI at Enterprise Scale

    • Making legacy R&D, clinical and commercial data AI-ready: master data, lineage and quality
    • Federated and privacy-preserving approaches to patient data across trusts and borders
    • Model ownership, validation and lifecycle monitoring inside a quality system
  4. Agentic AI in Regulatory & Safety

    Submissions, PV & Medical Writing

    • Agents in submissions, MLR review and pharmacovigilance case processing: real deployments and results
    • Evaluating and guardrailing autonomous systems in a GxP environment
    • Preparing for the FDA and EMA Good AI Practice principles, the EU AI Act and MHRA expectations
  5. Commercial & Medical Affairs

    Omnichannel, Agents & the Voice Channel

    • Next best action, HCP segmentation and omnichannel orchestration that proves ROI
    • Voice and agentic AI in the field and the contact centre: MSL copilots, medical information and AE intake
    • Compliance guardrails for AI-generated content under the ABPI Code and PMCPA
  6. Beyond Pilots

    The AI Operating Model & Workforce

    • Why most GenAI pilots stall, and what the programmes that reached production did differently
    • Central AI team versus federated teams: governance, funding and how value is measured
    • Building AI fluency across R&D, clinical, regulatory and commercial functions

Passes

Choose your pass

Senior leaders from qualifying organisations attend free, subject to confirmation. Service providers book a Delegate Pass; for a group, add each colleague by name with their own email.

Pharma & Biotech Ticket

Complimentary pass for C-Suite Executives & Directors. Subject to confirmation.

Free

Who qualifies

  • Pharmaceutical Manufacturers (AstraZeneca, Pfizer, GSK)
  • Biotechnology & Life-Science Companies
  • Contract Research Organisations (CROs)
  • Academic & Research Institutions
  • Regulators & Health Authorities (MHRA, EMA)
  • NHS Trusts & Clinical Trial Units
Apply for a complimentary place: Pharma & Biotech Ticket

You’ll answer a few questions about your organisation. Our team confirms eligible places by email.

Bring your team to London

Passes and sponsorship packages in one place. Questions go straight to info@worldpharma.ai.